ASAP Act Alzheimer’s Screening and Prevention Act of 2025
To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
HB6130, known as the ASAP Act or Alzheimer’s Screening and Prevention Act of 2025, proposes to amend Medicare to cover blood-based dementia screening tests. This means that seniors who are eligible for Medicare could potentially get tested for dementia through blood tests, which could lead to earlier detection and treatment of Alzheimer’s and other forms of dementia.
This bill would mainly affect Medicare beneficiaries, especially those who are at higher risk for dementia. By making these screening tests more accessible, the bill aims to improve early diagnosis and management of dementia, potentially enhancing the quality of life for those affected. The bill has been introduced and referred to relevant committees for further consideration.
As of the latest update, HB6130 was introduced on November 19, 2025, and was referred to the House Committee on Energy and Commerce and the Committee on Ways and Means. On September 16, 2026, the bill underwent committee consideration, where it was ordered to be reported in the nature of a substitute, with a unanimous vote of 40-0. This indicates the bill has progressed through the initial stages and is being prepared for further legislative action.
